| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8241666 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 9 Pages |
Abstract
Conclusions: Radical radiotherapy is the treatment of choice for early-stage (T1) diseases, whereas surgery (negative surgical margins if possible) with radiotherapy is recommended as the standard care for advanced (T2-3) disease. Further clarification on the role of chemotherapy is necessary.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Kazuhiko M.D., Katsumasa M.D., Kazuo M.D., Takashi M.D., Nobukazu M.D., Jun M.D., Shizuo M.D., Torahiko M.D., Akihiko M.D., Takashi M.D., Takafumi M.D., Mitsuhiro M.D., Takeshi M.D., Mikio M.D., Hisao M.D., Sadayuki M.D.,